GH Research PLC GHRS

Updated: 18 Jun 2026

NASDAQ | Biotech | Psychedelic-based therapies

No signal published yet

We already track GH Research and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow GH Research free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Psychedelic-based therapies
We're already tracking GH Research PLC — here are the latest events we've registered

Recent News

  • In June 2026, the company published Phase 2a results for GH001 in postpartum depression, showing rapid remission in all ten patients. Additionally, GH Research completed a $117.5 million underwritten offering in April 2026 to fund its ongoing clinical programs.

What Firelda Watch includes for GH Research PLC

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of GH Research PLC will be delivered in the same format.

Want to follow GH Research PLC? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow GH Research free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

GH Research PLC GHRS
GH Research — follow and we'll monitor it
Follow GH Research free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.